Corpus Intelligence IC Memo — AURORA MEDICAL CENTER - SUMMIT 2026-04-26 09:06 UTC
IC Memo — AURORA MEDICAL CENTER - SUMMIT
Investment Committee Memorandum | WI | 91 beds | Grade C | EBITDA uplift $14.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AURORA MEDICAL CENTER - SUMMIT

CCN 520206 | WAUKESHA, WI | 91 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

AURORA MEDICAL CENTER - SUMMIT is a 91-bed suburban community hospital in WAUKESHA, WI with $200.2M in net patient revenue and a 17.1% operating margin. The hospital serves a payer mix of 28.6% Medicare, 2.5% Medicaid, and 68.9% commercial.

Thesis: Turnaround. Our ML models identify $14.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.1% to 24.5% (+736bps).

Net Revenue HCRIS$200.2M
Current EBITDA COMPUTED$34.2M
Operating Margin COMPUTED17.1%
Occupancy HCRIS65.8%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS33.0%
Distress Probability ML43.0%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
38
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 17.1% places it above the state median. Among 38 size-comparable peers (46-182 beds), the median margin is -2.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (46-182), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AURORA MEDICAL CENTER - SUMMIT (Target)WI91$200.2M17.1%
BELLIN MEMORIAL HOSPITALWI175$652.3M13.7%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
MCHS FRANCISCAN HEALTHCARE INWI103$413.8M-7.2%
FROEDTERT SOUTHWI173$372.2M3.9%
THEDACARE REGIONAL MEDICAL CENWI172$352.3M7.0%
AURORA MEDICAL CENTER KENOSHAWI151$304.2M13.8%
AURORA MEDICAL CENTER GRAFTONWI132$300.4M16.7%
ST. AGNES HOSPITALWI77$275.9M-3.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.2M+210bp18mo
Cost to Collect4.5%2.5%$4.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$4.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.4M+122bp9mo
Clean Claim Rate88.0%96.0%$128K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.2M
Cost to Collect
$4.0M
Denial Rate Reduction
$4.0M
A/R Days Reduction
$2.4M
Clean Claim Rate
$128K
Total EBITDA Uplift$14.7M
Current EBITDA$34.2M
+ RCM Uplift+$14.7M
Pro Forma EBITDA$49.0M
Current Margin17.1%
Pro Forma Margin24.5%
WC Released (1x)$7.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$52.7M$373.1M7.09x47.9%
Base (11x exit)10.0x11.0x$52.7M$427.5M8.12x52.0%
Bull Case9.0x11.0x$47.4M$493.3M10.41x59.8%
Bull (12x exit)9.0x12.0x$47.4M$552.1M11.65x63.4%
Bear Case11.0x10.0x$57.9M$282.3M4.87x37.3%
Bear (11x exit)11.0x11.0x$57.9M$329.4M5.69x41.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 46-182 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-12.2% / P50=-2.6% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.